Breaking News Instant updates and real-time market news.
2019-01-09 16:07:18
FC
Franklin Covey
$22.88
-0.21 (-0.91%)
16:07
01/09/19
01/09
16:07
01/09/19
16:07
Franklin Covey backs FY19 adjusted EBITDA view $18M-$22M
09
Jan
FCFranklin Covey
$22.88
-0.21 (-0.91%)
04/05/18
BRRR
04/05/18 NO CHANGEBRRR
Franklin Covey price target raised to $35 from $32 at Barrington
Barrington analyst Alexander Paris Jr. reiterated his Outperform rating on Franklin Covey and raised his price target to $35 from $32 on the stock, after the company reported its Q2 earnings results, which had EBITDA that exceeded both the firm's and the consensus estimates. Going forward, Paris expects Franklin Covey to "achieve accelerated revenue growth, increasing gross margins and significantly increasing flow-through to adjusted EBITDA and cash flow, in FY18 and beyond."
04/06/18
ROTH
04/06/18 NO CHANGETarget $34 ROTH Buy
Franklin Covey price target raised to $34 from $26 at Roth Capital
Roth Capital analyst Jeff Martin raised his price target to $34 from $26 and reiterated his Buy rating following the company's Q2 earnings report. In a research note to investors, the analyst said the company's transition to a subscription-based model is making "significant" strides, with subscription and subscription-related revenue up 55% in the quarter to $20M, or 43% of revenue. Rising attach rates of add-on services, currently 40% and rising, combined with greater than 90% revenue retention should appeal to investors that favor subscription-based business models, the analyst said.
12/28/18
BRRR
12/28/18 NO CHANGEBRRR
Barrington sees increase in revenue , EBITDA in 2019 for Franklin Covey
Barrington analyst Alexander Paris reiterated an Outperform rating and $30 price target on Franklin Covey shares. The analyst sees a significant increase in revenue and adjusted EBITDA for the company in FY19 and beyond, as "the large amounts of high-profit margin deferred revenue become recognized as revenue and income." Paris added that he expects Franklin Covey to achieve accelerated revenue growth, "increasing gross margins and significantly increasing flow-through to adjusted EBITDA and cash flow in FY19 as significant growth investments begin to subside."